October 22, 2020 Comments Off on New patent expiration for Celgene drug POMALYST Posted in: Uncategorized
Annual Drug Patent Expirations for POMALYST Pomalyst is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
The post New patent expiration for Celgene drug POMALYST appeared fir…
October 22, 2020 Comments Off on New patent expiration for Celgene drug REVLIMID Posted in: Uncategorized
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are twenty patents protecting…
The post New patent expiration for Celgene drug REVLIMID appeared fir…